Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (4)

1

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189) : a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

enthalten in: The lancet / Oncology | March 2020

von Garassino, M. | Gadgeel, S. | Esteban, E. | +16

2

First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction

enthalten in: Journal of clinical oncology | February 8, 2016

von Gertz, M. | Landau, H. | Comenzo, R. | +11

3

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment : therapeutic implications

enthalten in: British journal of haematology | 19 September 2011

von Podar, K. | Zimmerhackl, A. | Fulciniti, M. | +10

4

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

enthalten in: Molecular cancer research | 8 September 2010

von Ceppi, P. | Mudduluru, G. | Kumarswamy, R. | +4

1
[1]